Atlas Trials

Nivolumab in Relapsed Pediatric Solid Tumors

Clinical trial NCT02901145 · UNKNOWN

Trial details

NCT number
NCT02901145
Sponsor
Hadassah Medical Organization
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Antibodies, Neoplasm
Start date
2016-11-01
Primary completion
2019-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.